PROVECTUS BIOPHARMACEUTICALS, INC. Debt Conversion, Original Debt, Amount
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Debt Conversion, Original Debt, Amount of $1.63 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2023-03-30
- PROVECTUS BIOPHARMACEUTICALS, INC. debt conversion, original debt, amount for fiscal 2022 was $1.63M, a 48.50% decline from fiscal 2021.
- PROVECTUS BIOPHARMACEUTICALS, INC. debt conversion, original debt, amount for fiscal 2021 was $3.16M, a 2.02% decline from fiscal 2020.
- PROVECTUS BIOPHARMACEUTICALS, INC. debt conversion, original debt, amount for fiscal 2020 was $3.23M.
| Period end | Debt Conversion, Original Debt, Amount 0 month | Debt Conversion, Original Debt, Amount 1 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|
| 2022-12-31 | $1.63M 10-K · filed 2023-03-30 | ||
| 2021-12-31 | $3.16M 10-K · filed 2023-03-30 | ||
| 2020-12-31 | $3.23M 10-K · filed 2022-03-29 | ||
| 2005-12-31 | $468.84K 10-K · filed 2014-03-13 | $468.84K 10-K · filed 2013-03-14 | |
| 2005-11-30 | $675.00K 10-K · filed 2014-03-13 | ||
| 2005-11-26 | $1.19M 10-K · filed 2014-03-13 | $1.19M 10-K · filed 2013-03-14 | |
| 2005-10-31 | $100.00K 10-K · filed 2014-03-13 | ||
| 2005-09-30 | $400.00K 10-K · filed 2014-03-13 | ||
| 2005-07-31 | $350.00K 10-K · filed 2014-03-13 | ||
| 2005-06-30 | $150.00K 10-K · filed 2014-03-13 | ||
| 2004-07-28 | $375.00K 10-K · filed 2014-03-13 | $375.00K 10-K · filed 2013-03-14 |